Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AXDX

Accelerate Diagnostics (AXDX) Stock Price, News & Analysis

Accelerate Diagnostics logo

About Accelerate Diagnostics Stock (NASDAQ:AXDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.03
$1.18
52-Week Range
N/A
Volume
53.64 million shs
Average Volume
560,214 shs
Market Capitalization
$857 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive AXDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

AXDX Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
See More Headlines

AXDX Stock Analysis - Frequently Asked Questions

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) released its quarterly earnings data on Thursday, March, 20th. The medical research company reported ($0.37) earnings per share for the quarter, topping the consensus estimate of ($0.50) by $0.13. The medical research company had revenue of $2.82 million for the quarter, compared to analyst estimates of $3 million.

Accelerate Diagnostics's stock reverse split before market open on Wednesday, July 12th 2023.The 1-10 reverse split was announced on Wednesday, July 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Accelerate Diagnostics investors own include Himax Technologies (HIMX), Sangamo Therapeutics (SGMO), Magnachip Semiconductor (MX), Universal Display (OLED), Energy Transfer (ET), Fluidigm (FLDM) and Netflix (NFLX).

Company Calendar

Last Earnings
3/20/2025
Today
7/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:AXDX
CIK
727207
Employees
220
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.62 million
Net Margins
-471.83%
Pretax Margin
-444.14%
Return on Equity
N/A
Return on Assets
-191.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.50
Quick Ratio
1.34

Sales & Book Value

Annual Sales
$11.70 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.37) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
25,210,000
Free Float
14,125,000
Market Cap
$857 thousand
Optionable
Optionable
Beta
0.22

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:AXDX) was last updated on 7/23/2025 by MarketBeat.com Staff
From Our Partners